- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/10 - IndolesHydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 209/10
Total number of patents in this class: 318
10-year publication summary
|
26
|
31
|
23
|
31
|
23
|
18
|
14
|
13
|
16
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Board of Regents, The University of Texas System | 5798 |
7 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 287 |
6 |
| Sunshine Lake Pharma Co., Ltd. | 599 |
6 |
| Emory University | 1631 |
5 |
| Nanoquantum Sciences, Inc. | 6 |
5 |
| Merck Sharp & Dohme LLC | 3742 |
5 |
| Boehringer Ingelheim International GmbH | 4644 |
4 |
| Merck Patent GmbH | 5818 |
4 |
| Cedars-Sinai Medical Center | 1159 |
4 |
| Dyomics GmbH | 19 |
4 |
| Northeastern University | 1192 |
4 |
| Oxagen Limited | 7 |
4 |
| Pierce Biotechnology, Inc. | 145 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2856 |
4 |
| Da Zen Theranostics, Inc. | 14 |
4 |
| New Mexico Tech University Research Park Corporation | 48 |
4 |
| Recurium IP Holdings, LLC | 134 |
4 |
| Novartis AG | 10829 |
3 |
| F. Hoffmann-La Roche AG | 7920 |
3 |
| BASF SE | 20915 |
3 |
| Other owners | 231 |